Biotech executive: Speed of vaccine development is due to ‘excellent science,’ not political pressure

Dr. Michelle McMurry-Heath, president of trade group Biotechnology Innovation Organization and a former FDA official, calls the White House’s politicization of science during the pandemic “unprecedented and unconscionable.”